REFERENCES
- Paterson D, Swindells S, Mohr J, et al. Adherence to pro-tease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.
- Rodriguez-Rosado R, Jimenez-Nacher I, Soriano V, Anton P, Gonzalez-Lahoz J. Virological failure and adherence to antiretroviral therapy in HIV-infected patients. A/DS.1998; 12:1112–1113.
- Bangsberg D, Hecht F, Charlebois E, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–366.
- Hecht F, Colfax G, Swanson M, Chesney M. Adherence and effectiveness of protease inhibitors in clinical practice. Presented at: Fifth Conference on Retrovirus and Opportu-nistic Infections; February 1998; Chicago. Abstract 151.
- Miller L, Hays R. Measuring adherence to antiretroviral medications in clinical trials. HIV Clin Trials. 2000;1 (1):36–46.
- Haubrich R, Little S, Currier J, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collabora-tive Treatment Group. AIDS. 1999;13:1099–1107.
- Frick P, Gal P, Lane T, Sewell M. Antiretroviral medication compliance in patients with AIDS. Aids Patient Care STDS.1998;12:463–470.
- Gifford A, Bormann J, Shively M, Wright B, Richman D, Bozzette S. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386–395.
- Holzemer W, Corless I, Nokes K, et al. Predictors of self-reported adherence in persons living with HIV disease. Aids Patient Care STDS. 1999;13:185–197.
- Singh N, Berman S, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29:824-830.
- Duong M, Piroth L, Forte F, Chavanet P, Portier H. Serum protease inhibitor level as a marker of adherence to HAART; correlation with self-reported adherence and HIV RNA. Presented at: 36th Interscience Conference on Anti-microbial Agents and Chemotherapy; September 1999; San Francisco. Abstract 2069.
- Murri R, Ammassari A, Gallicano K, et al. Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr. 2000;24:123–128.
- Chesney M, Ickovics J, Chambers D, et al. Self-reported adherence to antiretroviral medications among partici-pants in HIV clinical trials: The AACTG adherence instru-ments. AIDS Care. 2000;12(3):255–266.
- Eron J, Yetzer E, Ruane P, et al. Efficacy, safety, and adherence with a twice-daily combination lamivudine/ zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS. 2000;14:671–681.
- Childress J, Jhingran P, Scott-Lennox J, Tolson J. Devel-opment and initial evaluation of the Patient Medication Adherence Questionnaire. Presented at: Sixth European Conference on Clinical Aspects and Treatment of HIV In-fection; October 1997; Hamburg, Germany.
- Weiss L, French P, Finkelstein R, Waters M, Kluger M, Agins B. Knowledge, attitudes and adherence to HAART: Results of a multisite adherence evaluation project. Pre-sented at: 13th International AIDS Conference; July 2000; Durban, South Africa. Abstract ThPeB 5018.
- Mostashari F, Riley E, Selwyn P, Altice F. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J Acquir Immune Defic Syndr Hum Retroyirol. 1998;18:341–348.
- Valente S, Saunders J, Ulman G. Self-care, psychologycal distress and HIV disease. J Assoc Nurs AIDS Care. 1993; 4:15–25.
- Singh N, Squier C, Sivek C, Wagener M, Nguyen M, Yu V. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care.1996;8:261–269.
- Andrews L, Friedland G, Mannheimer S, et al. A method for assessing patient readiness to begin and adhere to HAART. Presented at: 13th International AIDS Conference; July 2000; Durban, South Africa. Abstract ThPeB 4987.